WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018

Jun 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-06-21

Reporting Person: Birkett Bernard (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-21	Common Stock	A	9908.00	$0.00	Acquired	9908.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-21	Stock Options (Right to buy)	$100.92	A	13884.00	Acquired	2028-06-21	Common Stock (13884.00)	Direct

Footnotes

F1: This award vests over four years starting on the first anniversary date of the award.

F2: This award vests in four equal annual installments beginning on June 21, 2019.